Quest Diagnostics (DGX) Divestments (2013 - 2016)

Quest Diagnostics' (DGX) quarterly Divestments came in at $25.0 million in Q4 2016, up 600.0% quarter-over-quarter from -$5.0 million in Q3 2016.

Quest Diagnostics (DGX) Divestments (2013 - 2016) Analysis & Trends

Quest Diagnostics has disclosed Divestments across 2 years of filings, most recently posting $25.0 million for Q4 2016.

Divestments for Q4 2016 came in at $25.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $25.0 million (changed N/A YoY), and the FY2021 annual result was $755.0 million, changed N/A from the prior year.
Divestments came in at $25.0 million for Q4 2016 at Quest Diagnostics, up from -$5.0 million in the prior quarter.
In the past five years, Divestments ranged from a high of $30.0 million in Q3 2013 to a low of -$5.0 million in Q3 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Waters	29,902.70 Bn	29,902.24 Bn	1.11 Bn	-
2	Thermo Fisher Scientific	175.99 Bn	172.74 Bn	7.74 Bn	-
3	Danaher	129.87 Bn	124.18 Bn	3.59 Bn	-
4	Idexx Laboratories	44.75 Bn	44.55 Bn	722.74 Mn	-
5	Agilent Technologies	37.52 Bn	35.72 Bn	990.00 Mn	-
6	Iqvia Holdings	30.91 Bn	28.94 Bn	1.36 Bn	-
7	Natera	30.21 Bn	29.11 Bn	696.04 Mn	-
8	Illumina	24.19 Bn	23.04 Bn	721.00 Mn	-
9	Mettler Toledo International	23.12 Bn	23.06 Bn	555.82 Mn	-
10	Quest Diagnostics	21.68 Bn	21.59 Bn	942.00 Mn	-

Download Data